Optionele productanalyse
Met uw toestemming gebruiken we privacyvriendelijke, beperkte analyses om te begrijpen welke onderzoeksroutes werken. We gebruiken geen advertentietrackers of sessieopnamen. U kunt deze keuze wijzigen in Voorkeuren. Lees het Privacybeleid.
NetEase, Inc.'s published Strong Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $73.4B | |
|---|---|---|
| Revenue (ttm) | 17.2B | |
| Net income (ttm) | 4.8B | |
| EPS (ttm) | $7.42 | |
| Shares out | 3.2B | |
| P/E (trailing) | 15.2x | |
| P/E (forward) | 11.2x | |
| Dividend | $2.92 (2.60%) | |
| Volume | 670,087 | |
| Beta | 0.77 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | Trend |
|---|---|---|---|---|---|
| Period | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $96.50B | $103.47B | $105.30B | $112.63B | +5.3% |
| Gross profit | $52.77B | $63.06B | $65.81B | $72.40B | +11.1% |
| Operating income | $19.63B | $27.71B | $29.58B | $35.83B | +22.2% |
| Net income | $20.34B | $29.42B | $29.70B | $33.76B | +18.4% |
| EPS (diluted) | $30.85 | $45.25 | $45.95 | $52.40 | +19.3% |
| EBITDA | $22.49B | $30.76B | $32.00B | $38.08B | +19.2% |
| R&D | $15.04B | $16.48B | $17.52B | $17.72B | +5.6% |
| SG&A | $18.10B | $18.87B | $18.70B | $18.85B | +1.4% |
Recent company headlines from major financial publishers.
A Bull case assumes NetEase successfully diversifies its revenue away from China with global hits, leading to a valuation re-rating toward international peer multiples (18x+).
The Base case reflects continued domestic dominance and modest international progress, valued using a 15-year moat-fade model and conservative terminal growth.
| Ke ↓ / g → | 2.0% | 2.5% | 3.0% | 3.5% | 4.0% |
|---|---|---|---|---|---|
| 6.7% | $216 | $241 | $274 | $311 | $311 |
| 7.7% | $178 | $195 | $216 | $241 | $274 |
| 8.7% | $151 | $163 | $178 | $195 | $216 |
| 9.7% | $132 | $141 | $151 | $163 | $178 |
| 10.7% | $116 | $124 | $132 | $141 | $151 |
Upcoming earnings date and setup when available.
De rating die de gepubliceerde researcheditie van elke maand droeg. Een rating vergelijkt de koers op de analysedatum met de fair value; het is geen overzicht van of de inschatting juist bleek.
| Jaar | jan | feb | mrt | apr | mei | jun | jul | aug | sep | okt | nov | dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |